<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">24751117</PMID>
      <DateCompleted>
        <Year>2016</Year>
        <Month>08</Month>
        <Day>18</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2018</Year>
        <Month>12</Month>
        <Day>02</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1545-7206</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>55</Volume>
            <Issue>4</Issue>
            <PubDate>
              <Year>2014</Year>
              <Season>Jul-Aug</Season>
            </PubDate>
          </JournalIssue>
          <Title>Psychosomatics</Title>
          <ISOAbbreviation>Psychosomatics</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Baclofen-induced manic symptoms: case report and systematic review.</ArticleTitle>
        <Pagination>
          <StartPage>326</StartPage>
          <EndPage>332</EndPage>
          <MedlinePgn>326-332</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.psym.2014.02.003</ELocationID>
        <ELocationID EIdType="pii" ValidYN="Y">S0033-3182(14)00038-3</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The gamma-aminobutyric acid type B receptor agonist baclofen is approved for spasticity and is used off-label for diverse types of addictive disorders, notably alcohol dependence. Baclofen may induce numerous neuropsychiatric adverse drug reactions, including behavioral disinhibition. However, this precise adverse drug reaction has never been assessed using either a validated causality algorithm or a scale for manic symptoms.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">We report a case of a 49-year-old male patient who exhibited de novo mania during treatment with baclofen for alcohol dependence. Symptoms were evaluated using the Young Mania Rating Scale, and the causality of baclofen was determined using the Naranjo algorithm. This case was also compared with other cases of baclofen-induced mania through a systematic literature review.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">Mr. X, taking 180 mg/d of baclofen, presented with mania and scored 24 of 44 on the Young Mania Rating Scale, and the imputability of baclofen was "probable" using the Naranjo algorithm (8 of 13). In addition, 4 other cases of baclofen-induced mania were reported in the literature; 3 cases had a bipolar I disorder history. Baclofen-induced manic symptoms occurred mostly during the dose-escalation phase.</AbstractText>
          <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Baclofen-induced manic symptoms may appear in patients with or without bipolar disorder. Particular attention is required during the dose-increase phase and in patients with a history of mood disorders.</AbstractText>
          <CopyrightInformation>Copyright © 2014 Academy of Psychosomatic Medicine. Published by Elsevier Inc. All rights reserved.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Geoffroy</LastName>
            <ForeName>Pierre Alexis</ForeName>
            <Initials>PA</Initials>
            <AffiliationInfo>
              <Affiliation>The University of Lille Nord de France, F-59000 Lille, France; Department of Psychiatry, Centre Hospitalier Universitaire de Lille (CHRU), F-59037 Lille, France. Electronic address: pierre.a.geoffroy@gmail.com.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Auffret</LastName>
            <ForeName>Marine</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>INSERM, UMR-S1144, VariaPsy, Equipe 1, 75010, Paris, France; Department of Pharmacology, EA 1046, Univ Lille Nord de France, F-59000 Lille, France(MA, SD, RB, BR).</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Deheul</LastName>
            <ForeName>Sylvie</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>INSERM, UMR-S1144, VariaPsy, Equipe 1, 75010, Paris, France; Department of Pharmacology, EA 1046, Univ Lille Nord de France, F-59000 Lille, France(MA, SD, RB, BR).</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Bordet</LastName>
            <ForeName>Régis</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>The University of Lille Nord de France, F-59000 Lille, France; INSERM, UMR-S1144, VariaPsy, Equipe 1, 75010, Paris, France; Department of Pharmacology, EA 1046, Univ Lille Nord de France, F-59000 Lille, France(MA, SD, RB, BR).</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Cottencin</LastName>
            <ForeName>Olivier</ForeName>
            <Initials>O</Initials>
            <AffiliationInfo>
              <Affiliation>The University of Lille Nord de France, F-59000 Lille, France; Department of Psychiatry, Centre Hospitalier Universitaire de Lille (CHRU), F-59037 Lille, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Rolland</LastName>
            <ForeName>Benjamin</ForeName>
            <Initials>B</Initials>
            <AffiliationInfo>
              <Affiliation>The University of Lille Nord de France, F-59000 Lille, France; Department of Psychiatry, Centre Hospitalier Universitaire de Lille (CHRU), F-59037 Lille, France; INSERM, UMR-S1144, VariaPsy, Equipe 1, 75010, Paris, France; Department of Pharmacology, EA 1046, Univ Lille Nord de France, F-59000 Lille, France(MA, SD, RB, BR).</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D002363">Case Reports</PublicationType>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
          <PublicationType UI="D000078182">Systematic Review</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2014</Year>
          <Month>02</Month>
          <Day>15</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Psychosomatics</MedlineTA>
        <NlmUniqueID>0376506</NlmUniqueID>
        <ISSNLinking>0033-3182</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D058786">GABA-B Receptor Agonists</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>H789N3FKE8</RegistryNumber>
          <NameOfSubstance UI="D001418">Baclofen</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <CommentsCorrectionsList>
        <CommentsCorrections RefType="CommentIn">
          <RefSource>Psychosomatics. 2017 Jan - Feb;58(1):94</RefSource>
          <PMID Version="1">28010752</PMID>
        </CommentsCorrections>
      </CommentsCorrectionsList>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000437" MajorTopicYN="N">Alcoholism</DescriptorName>
          <QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D001418" MajorTopicYN="N">Baclofen</DescriptorName>
          <QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName>
          <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D001714" MajorTopicYN="N">Bipolar Disorder</DescriptorName>
          <QualifierName UI="Q000139" MajorTopicYN="Y">chemically induced</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D058786" MajorTopicYN="N">GABA-B Receptor Agonists</DescriptorName>
          <QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2013</Year>
          <Month>12</Month>
          <Day>31</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2014</Year>
          <Month>2</Month>
          <Day>10</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2014</Year>
          <Month>2</Month>
          <Day>11</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2014</Year>
          <Month>4</Month>
          <Day>23</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2014</Year>
          <Month>4</Month>
          <Day>23</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2016</Year>
          <Month>8</Month>
          <Day>19</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">24751117</ArticleId>
        <ArticleId IdType="doi">10.1016/j.psym.2014.02.003</ArticleId>
        <ArticleId IdType="pii">S0033-3182(14)00038-3</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
